Loading insider details...
Latest Form 4 (Oct 1, 2026): Exercise/Conversion of 30,000 KYMR shares, $62.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 30,000 | $62.4K |
| Jul 8, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 50,000 | $104.0K |
| Jul 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 80,000 | $166.4K |
| Apr 29, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 30,000 | $62.4K |
| Mar 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 215,000 | n/a |
| Feb 25, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 30,000 | $62.4K |
| Jan 6, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 3,118 | $100.0K |
| Dec 31, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 30,000 | $62.4K |
| Dec 17, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 2,595 | $100.0K |
| Dec 8, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 100,000 | $208.0K |